Free from Publisher

Development and external validation of prognostic models for COVID-19 to support risk stratification in secondary care

NJ Adderley, T Taverner, MJ Price, C Sainsbury… - BMJ open, 2022 - bmjopen.bmj.com
Objectives Existing UK prognostic models for patients admitted to the hospital with COVID-
19 are limited by reliance on comorbidities, which are under-recorded in secondary care …
被引用次数：10 相关文章

Development and external validation of prognostic models for COVID-19 to support risk stratification in secondary care

NJ Adderley, T Taverner, MJ Price, C Sainsbury… - BMJ …, 2022 - search.proquest.com
Objectives Existing UK prognostic models for patients admitted to the hospital with COVID-
19 are limited by reliance on comorbidities, which are under-recorded in secondary care …
[PDF] bham.ac.uk

[PDF][PDF] Development and external validation of prognostic models for COVID-19 to support risk stratification in secondary care

NJ Adderley, T Taverner, MJ Price, C Sainsbury… - pure-oai.bham.ac.uk
Objectives Existing UK prognostic models for patients admitted to the hospital with COVID-
19 are limited by reliance on comorbidities, which are under-recorded in secondary care …

Development and external validation of prognostic models for COVID-19 to support risk stratification in secondary care

NJ Adderley, T Taverner, M Price, C Sainsbury… - medRxiv, 2021 - medrxiv.org
Objectives Existing UK prognostic models for patients admitted to hospital with COVID-19
are limited by reliance on comorbidities, which are under-recorded in secondary care, and …
[PDF] archive.org

[PDF][PDF] Development and external validation of prognostic models for COVID-19 to support risk stratification in secondary care

C Sainsbury, K Nirantharakumar - scholar.archive.org
Objectives Existing UK prognostic models for patients admitted to hospital with COVID-19
are limited by reliance on comorbidities, which are under-recorded in secondary care, and …

Development and external validation of prognostic models for COVID-19 to support risk stratification in secondary care

NJ Adderley, T Taverner, M Price, C Sainsbury… - 2021 - pesquisa.bvsalud.org
ObjectivesExisting UK prognostic models for patients admitted to hospital with COVID-19 are
limited by reliance on comorbidities, which are under-recorded in secondary care, and lack …
[PDF] academia.edu

[PDF][PDF] Development and external validation of prognostic models for COVID-19 to support risk stratification in secondary care

NJ Adderley, T Taverner, MJ Price, C Sainsbury… - academia.edu
Objectives Existing UK prognostic models for patients admitted to the hospital with COVID-
19 are limited by reliance on comorbidities, which are under-recorded in secondary care …
[HTML] nih.gov

[HTML][HTML] Development and external validation of prognostic models for COVID-19 to support risk stratification in secondary care

NJ Adderley, T Taverner, MJ Price, C Sainsbury… - BMJ Open, 2022 - ncbi.nlm.nih.gov
Objectives Existing UK prognostic models for patients admitted to the hospital with COVID-
19 are limited by reliance on comorbidities, which are under-recorded in secondary care …
[PDF] birmingham.ac.uk

[PDF][PDF] Development and external validation of prognostic models for COVID-19 to support risk stratification in secondary care

NJ Adderley, T Taverner, MJ Price, C Sainsbury… - research.birmingham.ac.uk
Objectives Existing UK prognostic models for patients admitted to the hospital with COVID-
19 are limited by reliance on comorbidities, which are under-recorded in secondary care …

Development and external validation of prognostic models for COVID-19 to support risk stratification in secondary care.

NJ Adderley, T Taverner, MJ Price, C Sainsbury… - 2022 - cabidigitallibrary.org
Objectives: Existing UK prognostic models for patients admitted to the hospital with COVID-
19 are limited by reliance on comorbidities, which are under-recorded in secondary care …